CorEvitas, the leading sponsor of registries in autoimmune and inflammatory diseases, and The Guthy-Jackson Charitable Foundation (GJCF) are pleased to announce that the SPHERES (Synergy of Prospective Health & Experimental Research for Emerging Solutions in NMOSD) Registry for Neuromyelitis Optica Spectrum Disorder (NMOSD) has reached an enrollment milestone of 200 patients.
A Mediaplanet Guide to Rare Diseases. This campaign was distributed with USA Today newspaper and launched on futureofpersonalhealth.com Click here to learn more.
In this dynamic episode, Meghan explores the origin and plague of “the B word” and its cousin “difficult” and how these terms are often wrongly…
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved Enspryng ™(satralizumab-mwge)…
The Huffington Post Victoria Jackson shuddered uncontrollably when the doctor told her and husband Bill in 2008 that their 14-year-old daughter, Ali, had an extremely…
A mother spends millions to fund research for neuromyelitis optica, which can leave patients paralyzed or blind LATimes By Sandy Banks November 28, 2009 Victoria…
